TY - JOUR
T1 - Accelerated Digital Biodetection Using Magneto-plasmonic Nanoparticle-Coupled Photonic Resonator Absorption Microscopy
AU - Che, Congnyu
AU - Xue, Ruiyang
AU - Li, Nantao
AU - Gupta, Prashant
AU - Wang, Xiaojing
AU - Zhao, Bin
AU - Singamaneni, Srikanth
AU - Nie, Shuming
AU - Cunningham, Brian T.
N1 - Funding Information:
This work is supported by the National Institutes of Health (NIH) R01 AI20683, R01 EB029805, and National Science Foundation (NSF) CBET 1900277. N.L. is supported by Zhejiang University ZJU-UIUC Joint Research Center (DREMES202001). B.Z. is supported by a Carl R. Woese Institute for Genomic Biology (IGB) fellowship in the Center for Genomic Diagnostics. The authors acknowledge the use of facilities and instrumentation supported by NSF through the University of Illinois Materials Research Science and Engineering Center DMR-1720633. The authors gratefully acknowledge the members of the Nanosensors Group (NSG) and staff in the Nick Holonyak Jr. Micro and Nanotechnology Laboratory for their support.
Publisher Copyright:
© 2022 American Chemical Society.
PY - 2022/2/22
Y1 - 2022/2/22
N2 - Rapid, ultrasensitive, and selective quantification of circulating microRNA (miRNA) biomarkers in body fluids is increasingly deployed in early cancer diagnosis, prognosis, and therapy monitoring. While nanoparticle tags enable detection of nucleic acid or protein biomarkers with digital resolution and subfemtomolar detection limits without enzymatic amplification, the response time of these assays is typically dominated by diffusion-limited transport of the analytes or nanotags to the biosensor surface. Here, we present a magnetic activate capture and digital counting (mAC+DC) approach that utilizes magneto-plasmonic nanoparticles (MPNPs) to accelerate single-molecule sensing, demonstrated by miRNA detection via toehold-mediated strand displacement. Spiky Fe3O4@Au MPNPs with immobilized target-specific probes are “activated” by binding with miRNA targets, followed by magnetically driven transport through the bulk fluid toward nanoparticle capture probes on a photonic crystal (PC). By spectrally matching the localized surface plasmon resonance of the MPNPs to the PC-guided resonance, each captured MPNP locally quenches the PC reflection efficiency, thus enabling captured MPNPs to be individually visualized with high contrast for counting. We demonstrate quantification of the miR-375 cancer biomarker directly from unprocessed human serum with a 1 min response time, a detection limit of 61.9 aM, a broad dynamic range (100 aM to 10 pM), and a single-base mismatch selectivity. The approach is well-suited for minimally invasive biomarker quantification, enabling potential applications in point-of-care testing with short sample-to-answer time.
AB - Rapid, ultrasensitive, and selective quantification of circulating microRNA (miRNA) biomarkers in body fluids is increasingly deployed in early cancer diagnosis, prognosis, and therapy monitoring. While nanoparticle tags enable detection of nucleic acid or protein biomarkers with digital resolution and subfemtomolar detection limits without enzymatic amplification, the response time of these assays is typically dominated by diffusion-limited transport of the analytes or nanotags to the biosensor surface. Here, we present a magnetic activate capture and digital counting (mAC+DC) approach that utilizes magneto-plasmonic nanoparticles (MPNPs) to accelerate single-molecule sensing, demonstrated by miRNA detection via toehold-mediated strand displacement. Spiky Fe3O4@Au MPNPs with immobilized target-specific probes are “activated” by binding with miRNA targets, followed by magnetically driven transport through the bulk fluid toward nanoparticle capture probes on a photonic crystal (PC). By spectrally matching the localized surface plasmon resonance of the MPNPs to the PC-guided resonance, each captured MPNP locally quenches the PC reflection efficiency, thus enabling captured MPNPs to be individually visualized with high contrast for counting. We demonstrate quantification of the miR-375 cancer biomarker directly from unprocessed human serum with a 1 min response time, a detection limit of 61.9 aM, a broad dynamic range (100 aM to 10 pM), and a single-base mismatch selectivity. The approach is well-suited for minimally invasive biomarker quantification, enabling potential applications in point-of-care testing with short sample-to-answer time.
KW - fast digital detection
KW - magneto-plasmonic nanoparticle
KW - microRNA
KW - photonic crystal
KW - strand displacement
UR - http://www.scopus.com/inward/record.url?scp=85123915858&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85123915858&partnerID=8YFLogxK
U2 - 10.1021/acsnano.1c08569
DO - 10.1021/acsnano.1c08569
M3 - Article
C2 - 35040633
AN - SCOPUS:85123915858
SN - 1936-0851
VL - 16
SP - 2345
EP - 2354
JO - ACS Nano
JF - ACS Nano
IS - 2
ER -